Stock NUVL NUVALENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Nuvalent, Inc.

Equities

NUVL

US6707031075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-05 pm EDT 		5-day change 1st Jan Change
73.57 USD +4.68% Intraday chart for Nuvalent, Inc. +11.40% -0.03%
May. 17 Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing MT
May. 16 Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment DJ

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nuvalent to Participate in the 2024 Jefferies Global Healthcare Conference
PR
Nuvalent Insider Sold Shares Worth $345,450, According to a Recent SEC Filing
MT
Nuvalent Gets FDA Breakthrough Therapy Designation for Lung-Cancer Treatment
DJ
Nuvalent Gets Breakthrough Therapy Designation for Lung Cancer Treatment Candidate
MT
Nuvalent, Inc. Receives U.S. FDA Breakthrough Therapy Designation for NVL-655
CI
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
AQ
Nuvalent Q1 Net Loss Widens
MT
Nuvalent, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Nuvalent Insider Sold Shares Worth $2,605,525, According to a Recent SEC Filing
MT
Nuvalent Insider Sold Shares Worth $2,666,555, According to a Recent SEC Filing
MT
Nuvalent Insider Sold Shares Worth $2,458,335, According to a Recent SEC Filing
MT
Jefferies Initiates Nuvalent With Buy Rating, $97 Price Target
MT
Nuvalent Insider Sold Shares Worth $2,566,479, According to a Recent SEC Filing
MT
North American Morning Briefing : Stocks Seen -2-
DJ
Nuvalent Insider Sold Shares Worth $1,654,311, According to a Recent SEC Filing
MT
Leerink Partners Upgrades Nuvalent to Outperform From Market Perform, Raises Price Target to $110 From $69
MT
Nuvalent Insider Sold Shares Worth $3,032,528, According to a Recent SEC Filing
MT
Nuvalent Insider Sold Shares Worth $1,550,229, According to a Recent SEC Filing
MT
BMO Capital Raises Price Target on Nuvalent to $102 From $93, Maintains Outperform Rating
MT
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NUVL Stock
  4. News Nuvalent, Inc.